The anticancer multi-kinase inhibitor dovitinib also targets topoisomerase I and topoisomerase II

Autor: Hasinoff, Brian B., Wu, Xing, Nitiss, John L., Kanagasabai, Ragu, Yalowich, Jack C.
Zdroj: In Biochemical Pharmacology 15 December 2012 84(12):1617-1626
Databáze: ScienceDirect